Amylyx Pharmaceuticals Inc
AMLX
$28.78-1.71%
Delayed · as of Sep 30, 2026, 2:02 PM ET
Mkt cap
$561.59M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-1.41
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
-0.59
Div yield
N/A
Sector
Healthcare
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
Use this AMLX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AMLX income, balance, and cash tables.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company in the Healthcare sector.
Latest cached Amylyx Pharmaceuticals Inc (AMLX) net income for Dec 31, 2025 was -$144.7M. Statements: https://lician.com/financials/amlx
Amylyx Pharmaceuticals Inc (AMLX) market capitalization is $561.6M on the latest cached snapshot.
Amylyx Pharmaceuticals Inc (AMLX) cached previous close $29.28; day range $28.78 – $29.62; volume 333,349. Session quote: https://lician.com/quote/amlx
Amylyx Pharmaceuticals Inc (AMLX) latest cached earnings event is "AMLX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AMLX filing is 8-K · Sep 8, 2026. Filings: https://lician.com/sec/amlx